Try our Advanced Search for more refined results
Competition
-
November 06, 2025
CareFirst Urges Ban On J&J Character Talk At Stelara Trial
Health insurer CareFirst is asking a Virginia federal judge to bar Johnson & Johnson from promoting its "good character" to a jury that will weigh class claims of anticompetitive conduct and patent fraud to extend market protection on the blockbuster autoimmune drug Stelara.
-
November 06, 2025
PayPal Beats Antitrust Suit Over Merchant Rules Again
PayPal has for a second time beat a proposed class action accusing it of illegally boosting online retail prices with restrictive merchant agreements, but the consumers have one more chance to amend.
-
November 06, 2025
Sinclair Says Disney-YouTube Blackout An Antitrust Problem
Sinclair's CEO expressed frustration about the ongoing blackout of Disney programming on YouTube TV, saying the dispute between media giants raises potential antitrust concerns because local broadcasters whose stations are affiliated with Disney's ABC broadcast network have no say over whether their content is getting distributed to viewers.
-
November 06, 2025
Sutter Health Patients' Attys To Get Over $100M Fees, Costs
A California U.S. magistrate judge said Thursday that she is ready to grant final approval of a $228.5 million deal settling a 13-year case over claims that Sutter Health boosted costs by pushing all-or-nothing networks on insurers, which includes $75.4 million in attorney fees and over $28 million in litigation expenses.
-
November 06, 2025
Ex-COO Says Yale New Haven Hospital Owes Him Nearly $1M
Yale New Haven Hospital owes its former chief operating officer more than $994,000 under a noncompete agreement that guarantees him regular payments, according to a Connecticut federal lawsuit claiming that the hospital is improperly withholding the money because he supposedly did not give enough notice of his resignation.
-
November 06, 2025
Edwards Defends $945M Heart Valve Deal From FTC Challenge
Edwards Lifesciences urged a D.C. federal court to reject the Federal Trade Commission's bid to put its planned $945 million acquisition of JenaValve on hold, saying the deal will increase innovation and save the lives of thousands of people with a form of heart valve disease.
-
November 06, 2025
Judge Mehta 'Still Digging Out' From Google, Oath Keepers
U.S. District Judge Amit P. Mehta said Thursday he is still playing catch-up from a period during which his time was spent with virtually nothing but the Google search case and the prosecution of Oath Keepers charged with sedition and other crimes from the Jan. 6 storming of the U.S. Capitol.
-
November 06, 2025
Google-Epic Judge Raises Doubts About App Antitrust Deal
The California federal judge overseeing Epic Games' antitrust suit against Google expressed serious doubts Thursday about their recent deal to end their fight over Android app distribution, ordering an evidentiary hearing and warning he's not sure the proposed deal will correct Google's illegal conduct.
-
November 06, 2025
Deutsche Börse And Nasdaq Face EU Derivatives Cartel Probe
The European Commission revealed Thursday that it is investigating Deutsche Börse and Nasdaq over possible collusion to avoid competing for the listing, trading and clearing of financial derivatives.
-
November 05, 2025
DOJ Clears Google's $32B Deal To Buy Cybersecurity Co. Wiz
Google's plan to acquire Wiz for $32 billion and integrate the growing cloud security platform into Google Cloud has cleared the U.S. Department of Justice's antitrust review, the tech giant confirmed Wednesday.
-
November 05, 2025
Helium Financial Says Fired Employees Nabbed Trade Secrets
Two former employees of Washington-based Helium Financial Group LLC stole trade secrets and used them to start their own wealth management firm after they were fired, allowing them to create "a 'clone' of Helium's business model in startup form," Helium claimed in a lawsuit filed Wednesday in Seattle federal court
-
November 05, 2025
Mallinckrodt Faces Antitrust Suit Over Oxycodone Supply Halt
A generic-drug company has claimed in a lawsuit filed in Pennsylvania federal court that Mallinckrodt LLC and a subsidiary have cut off the supply of active ingredients necessary to make competing drugs that include oxycodone and acetaminophen.
-
November 05, 2025
Pharmacy Groups Urge 8th Circ. To Back Ark. PBM Limits
A pair of pharmacy trade groups is urging the Eighth Circuit to allow Arkansas to enforce a law barring pharmacy benefit managers from owning pharmacies, arguing the law is a rational response to "abusive" PBM practices.
-
November 05, 2025
AGs Defend Bid To Intervene In DOJ's HPE Merger Deal
More than a dozen Democratic attorneys general have assailed the Justice Department and Hewlett Packard Enterprise for fighting their bid to peek behind the controversial settlement clearing HPE's $14 billion purchase of Juniper Networks, telling a California federal judge that Congress created court oversight for deals just like this.
-
November 05, 2025
Microsoft Wants To Weigh In On Google Search Fixes, Too
Microsoft is urging a D.C. federal court to make sure that the limits imposed on Google in the U.S. Department of Justice's search monopolization case prevent the search giant from inking multiyear default agreements and that they reach new types of generative artificial intelligence products.
-
November 05, 2025
Mamdani Taps Ex-FTC Chief Lina Khan For NYC Transition
New York City Mayor-elect Zohran Mamdani on Wednesday named an all-woman transition team, including former Federal Trade Commission Chair Lina Khan, who attracted the ire of tech giants and corporations by spearheading the Biden administration's aggressive antitrust enforcement.
-
November 05, 2025
Apple, Google CEOs Can't Yet Be Deposed In Antitrust Suit
Consumers accusing Google of hatching a deal with Apple to make it the default search engine on the iPhone will not be allowed to depose Apple CEO Tim Cook and Google CEO Sundar Pichai as part of their antitrust case accusing Google of suppressing rival search engines.
-
November 05, 2025
FTC Wants 'Tainted' Drs. Testimony Barred From Merger Case
The Federal Trade Commission wants a D.C. federal judge to bar a pair of outside doctors and consultants from vouching for Edwards Lifesciences' planned JenaValve acquisition, arguing in a filing made public Tuesday that claims of minimal communication between the physicians' counsel and the companies were "at best, misleading."
-
November 05, 2025
Chancery Won't Let Pfizer Block $10B Novo Bid For Metsera
A Delaware vice chancellor Wednesday refused Pfizer Inc.'s emergency bid for a temporary restraining order to block Metsera Inc. from closing a now $10 billion competing bid by Novo Nordisk for the GLP-1 weight-loss drugmaker, saying Pfizer hasn't demonstrated Metsera's board acted in bad faith or that the company would suffer immediate irreparable harm.
-
November 05, 2025
Google Reaches Deal With Epic For Android App Changes
Google has agreed to make a number of changes to the way apps are distributed on Android devices in a deal with Epic Games, potentially resolving their yearslong antitrust battle after Google asked the U.S. Supreme Court to take up the case.
-
November 04, 2025
Hagens Berman Owes $2M Over Failed Suit, Tech Giants Say
Amazon and Apple have told a Seattle federal judge that Hagens Berman Sobol Shapiro LLP should cover nearly $2 million in defense costs because of the firm's "misrepresentations" while litigating a lawsuit accusing the two companies of conspiring to limit device sales on the e-commerce platform.
-
November 04, 2025
NASCAR Has Monopoly, Judge Rules Ahead Of Antitrust Trial
NASCAR has a monopoly over premier stock car racing, a North Carolina federal judge ruled late Tuesday in handing two teams — including one owned by basketball legend Michael Jordan — a pretrial win on what the judge described as "two core elements" of their antitrust case.
-
November 04, 2025
DOJ, Google Spar Over Breakup Bid In Ad Tech Case
The U.S. Department of Justice is continuing to push a Virginia federal court to force Google to sell its ad exchange in the monopolization case over the company's advertising placement technology while Google is asking the court to impose more modest behavioral remedies.
-
November 04, 2025
Feds Tell 11th Circ. Delta, Aeromexico Can't Halt JV Split Order
The Trump administration fired back at Delta Air Lines and Aeromexico's Eleventh Circuit bid to freeze a U.S. Department of Transportation order directing them to scuttle their joint venture by Jan. 1, saying the airlines' contention that it'd be too burdensome to disentangle their networks is overblown.
-
November 04, 2025
NJ Slams Investment Fund's Appeal For Emails In Bias Suit
New Jersey state officials have urged a federal court to uphold a magistrate judge's ruling shielding three internal emails from disclosure in the racial discrimination lawsuit brought by Blueprint Capital Advisors LLC, arguing the communications are protected by executive and attorney-client privilege and are irrelevant to the firm's claims.
Expert Analysis
-
Opinion
The BigLaw Settlements Are About Risk, Not Profit
The nine Am Law 100 firms that settled with the Trump administration likely did so because of the personal risk faced by equity partners in today's billion‑dollar national practices, enabled by an ethics rule primed for modernization, says Adam Forest at Scale.
-
Current Antitrust Zeitgeist May Transcend Political Parties
The Trump administration's "America First" antitrust policy initially suggests a different approach than the Biden administration's, but closer examination reveals key parallels, including a broad focus on anticompetitive harm beyond consumer welfare and aggressive enforcement of existing laws, say attorneys at Arnold & Porter.
-
Opinion
Courts Must Revitalize Robust Claim Construction
Two Federal Circuit decisions from earlier this year illustrate the rarity of robust claim construction and the underused reverse doctrine of equivalents — a dual problem that prevents courts from clearly delineating and correctly cabining the scope of rights conferred by patent claims, say attorneys at Klarquist Sparkman.
-
State Tort Claims May Help Deter Bribes During FCPA Pause
As the U.S. pauses Foreign Corrupt Practices Act enforcement, companies that lose business due to competitors' bribery should consider using state tortious interference suits to expose corruption, deter illegal practices and obtain compensation for commercial losses, says Jason Manning at Levy Firestone.
-
Google Ad Tech Ruling Creates Antitrust Uncertainty
A Virginia federal court’s recent decision in the Justice Department’s ad tech antitrust case against Google includes two unusual aspects in that it narrowly construed U.S. Supreme Court precedent when rejecting Google's two-sided market argument, and it found the company liable for unlawful tying, say attorneys at Ballard Spahr.
-
Series
Brazilian Jiujitsu Makes Me A Better Lawyer
Competing in Brazilian jiujitsu – often against opponents who are much larger and younger than me – has allowed me to develop a handful of useful skills that foster the resilience and adaptability necessary for a successful legal career, says Tina Dorr of Barnes & Thornburg.
-
Pace Of Early Terminations Suggests Greater M&A Scrutiny
The nascent return of early termination under the Hart-Scott-Rodino Act shows a more limited use than before its 2021 suspension under the Biden administration's Federal Trade Commission, suggesting deeper scrutiny of mergers and acquisitions across the board, says Michael Wise at Squire Patton.
-
And Now A Word From The Panel: A Rare MDL Petition Off-Day
In an unusual occurrence in the Judicial Panel on Multidistrict Litigation's history, there are zero new MDL petitions scheduled for Thursday's hearing session, but the panel will be busy considering a host of motions regarding whether to transfer cases to eight existing MDL proceedings, says Alan Rothman at Sidley.
-
Customs Fraud Enforcement In The Age Of Tariffs
In the wake of the Trump administration’s new approach toward tariffs, two recent Justice Department developments demonstrate aggressive customs fraud enforcement, with the DOJ emphasizing competitive harm to American businesses, and signaling that investigations will likely involve both civil and criminal enforcement tools, say attorneys at Bernstein Litowitz and London & Naor.
-
Series
Power To The Paralegals: An Untapped Source For Biz Roles
Law firms looking to recruit legal business talent should consider turning to paralegals, who practice several key skills every day that prepare them to thrive in marketing and client development roles, says Vanessa Torres at Lowenstein Sandler.
-
The Legal Risks Of US Restrictions On Investments In China
The second Trump administration has continued to embrace a more restrictive economic policy toward China, including an ongoing review of further restrictions on the flow of U.S. capital to China, so early planning and enhanced diligence can reduce exposure to the challenges resulting from further restrictions, say attorneys at Cleary.
-
Series
Playing Poker Makes Me A Better Lawyer
Poker is a master class in psychology, risk management and strategic thinking, and I’m a better attorney because it has taught me to read my opponents, adapt when I’m dealt the unexpected and stay patient until I'm ready to reveal my hand, says Casey Kingsley at McCreadyLaw.
-
4 Ways Slater Is Priming DOJ For Continued Antitrust Success
Just as Jonathan Kanter did during his recent tenure leading the U.S. Department of Justice's Antitrust Division, Assistant Attorney General Gail Slater is following the effective blueprint set by Thurman Arnold when he modernized the division more than 80 years ago, says Perry Apelbaum at Kressin Powers.
-
What EU 'Killer Acquisition' Study Means For Pharma Deals
The European Commission’s recent study of pharmaceutical companies' acquisitions of emerging competitive threats, the first of its kind globally, has important implications for the industry, and may lead to increased awareness of merger control risks in collaborative agreements, say lawyers at Paul Weiss.
-
Why Texas Should Slow Down On Healthcare Merger Bills
More time is needed to study three Texas bills aimed at considering the effects of healthcare consolidation to increase affordability and access to healthcare, which could have the opposite effect, say John Saran and Harshita Rathore at Holland & Knight and Robbie Allen at U.S. Heart and Vascular.